Which test should the nurse anticipate discussing with a patient who has a possible seizure disorder?

Choice A rationale

Baclofen is a skeletal muscle relaxant primarily used to alleviate spasticity. It does not have a known pharmacological action that directly stimulates appetite. Appetite regulation is a complex physiological process influenced by various hormones and neurological pathways distinct from baclofen's mechanism of action.

Choice B rationale

Baclofen is a gamma-aminobutyric acid (GABA) mimetic that acts on GABA-B receptors in the spinal cord, inhibiting monosynaptic and polysynaptic reflexes. This action reduces the frequency and severity of muscle spasms and spasticity, which are common and debilitating symptoms in multiple sclerosis.

Choice C rationale

Baclofen is not an antibiotic or an antiseptic, and therefore, it does not reduce the urine bacterial count. Its primary therapeutic effect is on the central nervous system to reduce muscle tone. Urinary tract infections are common in multiple sclerosis due to bladder dysfunction, but baclofen does not directly treat them.

Choice D rationale

While some muscle relaxants can have sedating effects as a side effect, the primary therapeutic goal of baclofen in multiple sclerosis is to relieve muscular spasticity, not to induce sleep. Although it can cause drowsiness, it is not prescribed as a hypnotic or for the sole purpose of promoting sleep.

Choice A rationale

Ciprofloxacin absorption can be significantly impaired by antacids containing aluminum, magnesium, or calcium. These antacids bind to ciprofloxacin, forming insoluble complexes that reduce the antibiotic's bioavailability, thus diminishing its effectiveness in treating the infection.

Choice B rationale

Ciprofloxacin, a fluoroquinolone antibiotic, carries a black box warning for increased risk of tendinitis and tendon rupture. Patients should be instructed to monitor for tendon pain, especially in the Achilles tendon, and report it immediately to prevent severe and permanent injury.

Choice C rationale

Limiting fluid intake is contraindicated when taking ciprofloxacin for a UTI. Adequate hydration is crucial to help flush bacteria from the urinary tract and prevent crystalluria, a potential side effect where drug crystals form in the urine, which can lead to kidney damage.

Choice D rationale

Ciprofloxacin does not typically cause urine to turn dark orange. This side effect is more commonly associated with other medications, such as rifampin or phenazopyridine (a urinary analgesic), and is not an expected or normal finding when taking ciprofloxacin.